All In MedTech

Device Trial Radar · NCT03628378

Orthosensor vs Conventional Total Knee Arthroplasty

Outcomes in Free-hand Versus Sensor-guided Balancing in Total Knee Arthroplasty: a Randomized Controlled Trial

Last checked: Nov 19, 2026Latest source record: Sep 24, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 130 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

130

Actual

Start

Dec 20, 2017

Primary completion

Jun 22, 2022

Study completion Jun 22, 2022

Sponsor

Lead sponsor
Columbia UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 14, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

In a randomized-controlled fashion, this investigation will evaluate the use of the Verasense technology to achieve optimal TKA balance. Patients will be randomized to either: 1) undergo manual soft tissue balancing or 2) soft tissue balancing with the Verasense. The primary outcomes of interest will include patient-reported outcomes as well knee range of motion at 3 months, 6 months, 1 year, and 2 years. Secondary outcomes of interest will include pain level as assessed by the visual analogue scale (VAS) in the acute post-operative and follow up periods, ambulation distance during inpatient physical therapy postoperatively, surgical time, tourniquet time, amount of opioid consumption, length of hospital stay, incidence of arthrofibrosis and subsequent manipulation under anesthesia. The investigators hypothesize that the use of the Verasense technology will lead to improved soft tissue balancing in TKA and ultimately result in favorable patient-reported outcomes and postoperative knee range of motion.

Conditions

  • Osteoarthritis, Knee

Interventions

  • VerasenseDevice

    Ligamentous balancing device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Average Score on the 12-Item Short Form Survey (SF-12) - Physical ComponentTime frame: 3 months, 1 year, 2 years
  2. Average Score on the 12-Item Short Form Survey (SF-12) - Mental ComponentTime frame: 3 months, 1 year, 2 years
  3. Average Score on the WOMAC Functional (F) Limitation SubscaleTime frame: 3 months, 1 year, 2 years

4 more outcomes with a free account

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • NewYork-Presbyterian Lawrence Hospital

    Bronxville, New York

  • Columbia University Irving Medical Center

    New York, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.